TALK Insider Transactions
| Transaction Date (SEC Report ) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
|---|---|---|---|---|---|---|---|---|
| 2022-09-26 | Braunstein Douglas L | director | 1,833,416 | A-Award | A | 168,032 | 0.95 | 159,630.40 |
| 2022-09-26 | Pawar Madhu | director | 183,416 | A-Award | A | 168,032 | 0.95 | 159,630.40 |
| 2022-09-26 | YEANEY JACQUELINE E | director | 183,416 | A-Award | A | 168,032 | 0.95 | 159,630.40 |
| 2022-09-26 | Warfield Curtis | director | 183,416 | A-Award | A | 168,032 | 0.95 | 159,630.40 |
| 2022-09-26 | Cohen Jon R | director | 200,211 | A-Award | A | 200,211 | 1.00 | 200,211.00 |
| 2022-09-26 | Cohen Jon R | director | 78,765 | A-Award | A | 78,765 | 0.95 | 74,826.75 |
| 2022-09-26 | Shachar Erez | director | 183,416 | A-Award | A | 168,032 | 0.95 | 159,630.40 |
| 2022-09-26 | Hansen Michael E | director | 200,211 | A-Award | A | 200,211 | 1.00 | 200,211.00 |
| 2022-09-26 | Hansen Michael E | director | 78,765 | A-Award | A | 78,765 | 0.95 | 74,826.75 |
| 2022-09-20 | Reilly John Charles | officer: General Counsel and Secretary | 539,924 | P-Purchase | A | 5,000 | 0.90 | 4,500.00 |
| 2022-09-20 | Reilly John Charles | officer: General Counsel and Secretary | 534,924 | P-Purchase | A | 5,000 | 1.00 | 5,000.00 |
| 2022-09-15 | Margolin Gil | officer: Chief Technology Officer | 135,953 | S-Sale | D | 32,641 | 1.11 | 36,081.36 |
| 2022-09-15 | BERG CHARLES | director | 50,047 | A-Award | A | 34,663 | 1.15 | 39,862.45 |
| 2022-09-15 | Crowe Jeffrey | director | 50,047 | A-Award | A | 34,663 | 1.15 | 39,862.45 |
| 2022-09-14 | Margolin Gil | officer: Chief Technology Officer | 168,594 | S-Sale | D | 55,800 | 1.11 | 61,960.32 |
| 2022-09-02 | Braunstein Samara H. | officer: Chief Marketing Officer | 227,486 | F-InKind | D | 2,747 | 1.33 | 3,653.51 |
| 2022-09-02 | Braunstein Samara H. | officer: Chief Marketing Officer | 230,233 | F-InKind | D | 2,789 | 1.33 | 3,709.37 |
| 2022-09-02 | Fulk Jennifer | officer: Chief Financial Officer | 446,302 | F-InKind | D | 8,873 | 1.33 | 11,801.09 |
| 2022-09-02 | Fulk Jennifer | officer: Chief Financial Officer | 455,175 | F-InKind | D | 6,173 | 1.33 | 8,210.09 |
| 2022-09-02 | Reilly John Charles | officer: General Counsel and Secretary | 529,924 | F-InKind | D | 3,701 | 1.33 | 4,922.33 |
| 2022-09-02 | Reilly John Charles | officer: General Counsel and Secretary | 533,625 | F-InKind | D | 1,395 | 1.33 | 1,855.35 |
| 2022-09-02 | Margolin Gil | officer: Chief Technology Officer | 224,394 | F-InKind | D | 2,873 | 1.33 | 3,821.09 |
| 2022-09-02 | Margolin Gil | officer: Chief Technology Officer | 227,267 | F-InKind | D | 2,796 | 1.33 | 3,718.68 |
| 2022-09-02 | Boyd Erin | officer: Chief Growth Officer | 132,853 | F-InKind | D | 2,150 | 1.33 | 2,859.50 |
| 2022-06-02 | Boyd Erin | officer: Chief Growth Officer | 45,563 | A-Award | D | 45,563 | 1.61 | 73,356.43 |
| 2022-06-02 | Boyd Erin | officer: Chief Growth Officer | 40,000 | A-Award | D | 40,000 | 3.65 | 146,000.00 |
| 2022-06-02 | Boyd Erin | officer: Chief Growth Officer | 135,003 | F-InKind | D | 2,150 | 0.00 | 0.00 |
| 2022-06-02 | Margolin Gil | officer: Chief Technology Officer | 230,063 | F-InKind | D | 2,722 | 0.00 | 0.00 |
| 2022-06-02 | Margolin Gil | officer: Chief Technology Officer | 232,785 | F-InKind | D | 2,650 | 0.00 | 0.00 |
| 2022-06-02 | Braunstein Samara H. | officer: Chief Marketing Officer | 233,022 | F-InKind | D | 3,069 | 0.00 | 0.00 |
| 2022-06-02 | Braunstein Samara H. | officer: Chief Marketing Officer | 236,091 | F-InKind | D | 3,118 | 0.00 | 0.00 |
| 2022-06-02 | Fulk Jennifer | officer: Chief Financial Officer | 461,348 | F-InKind | D | 6,173 | 0.00 | 0.00 |
| 2022-06-02 | Reilly John Charles | officer: General Counsel and Secretary | 535,020 | F-InKind | D | 3,701 | 0.00 | 0.00 |
| 2022-06-02 | Reilly John Charles | officer: General Counsel and Secretary | 538,721 | F-InKind | D | 1,395 | 0.00 | 0.00 |
| 2022-05-09 | Braunstein Douglas L | director, 10 percent owner, officer: Excludes securities beneficially owned by Samara Braunstein. Interim Chief Executive Officer | 640,000 | A-Award | A | 640,000 | 1.22 | 780,800.00 |
| 2022-05-09 | Braunstein Douglas L | director, 10 percent owner, officer: Excludes securities beneficially owned by Samara Braunstein. Interim Chief Executive Officer | 1,665,384 | A-Award | A | 1,650,000 | 0.00 | 0.00 |
| 2022-03-08 | Margolin Gil | officer: Chief Technology Officer | 287,419 | M-Exempt | D | 236,356 | 0.51 | 120,541.56 |
| 2022-03-08 | Margolin Gil | officer: Chief Technology Officer | 0 | M-Exempt | D | 253,094 | 0.39 | 98,706.66 |
| 2022-03-08 | Margolin Gil | officer: Chief Technology Officer | 235,435 | S-Sale | D | 500,000 | 1.50 | 747,700.00 |
| 2022-03-08 | Margolin Gil | officer: Chief Technology Officer | 735,435 | M-Exempt | A | 236,356 | 0.51 | 120,541.56 |
| 2022-03-08 | Margolin Gil | officer: Chief Technology Officer | 499,079 | M-Exempt | A | 253,094 | 0.39 | 98,706.66 |
| 2022-03-01 | Boyd Erin | officer: Chief Growth Officer | 137,153 | A-Award | A | 127,153 | 0.00 | 0.00 |
| 2022-03-01 | Reilly John Charles | officer: General Counsel and Secretary | 58,851 | A-Award | A | 58,851 | 1.61 | 94,750.11 |
| 2022-03-01 | Reilly John Charles | officer: General Counsel and Secretary | 36,623 | M-Exempt | A | 20,083 | 1.22 | 24,501.26 |
| 2022-03-01 | Reilly John Charles | officer: General Counsel and Secretary | 25,604 | M-Exempt | A | 39,075 | 1.21 | 47,280.75 |
| 2022-03-01 | Reilly John Charles | officer: General Counsel and Secretary | 540,116 | J-Other | D | 1,360 | 1.61 | 2,189.60 |
| 2022-03-01 | Reilly John Charles | officer: General Counsel and Secretary | 541,476 | A-Award | A | 164,239 | 0.00 | 0.00 |
| 2022-03-01 | Braunstein Samara H. | officer: Chief Marketing Officer | 43,664 | A-Award | A | 43,664 | 1.61 | 70,299.04 |
| 2022-03-01 | Braunstein Samara H. | officer: Chief Marketing Officer | 239,209 | J-Other | D | 3,118 | 1.61 | 5,019.98 |
| 2022-03-01 | Braunstein Samara H. | officer: Chief Marketing Officer | 242,327 | A-Award | A | 121,855 | 0.00 | 0.00 |
| 2022-03-01 | Fulk Jennifer | officer: Chief Financial Officer | 123,398 | A-Award | A | 123,398 | 1.61 | 198,670.78 |
| 2022-03-01 | Fulk Jennifer | officer: Chief Financial Officer | 467,521 | A-Award | A | 344,371 | 0.00 | 0.00 |
| 2022-03-01 | Margolin Gil | officer: Chief Technology Officer | 45,563 | A-Award | A | 45,563 | 1.61 | 73,356.43 |
| 2022-03-01 | Margolin Gil | officer: Chief Technology Officer | 245,985 | J-Other | D | 2,365 | 1.61 | 3,807.65 |
| 2022-03-01 | Margolin Gil | officer: Chief Technology Officer | 248,350 | A-Award | A | 127,153 | 0.00 | 0.00 |
| 2022-02-05 | Reilly John Charles | officer: General Counsel and Secretary | 377,237 | M-Exempt | A | 20,083 | 1.22 | 24,501.26 |
| 2022-02-04 | Reilly John Charles | officer: General Counsel and Secretary | 357,154 | M-Exempt | A | 39,075 | 1.21 | 47,280.75 |
| 2021-12-06 | Reilly John Charles | officer: General Counsel and Secretary | 0 | M-Exempt | D | 67,792 | 0.39 | 26,438.88 |
| 2021-12-06 | Reilly John Charles | officer: General Counsel and Secretary | 319,554 | M-Exempt | A | 67,792 | 0.39 | 26,438.88 |
| 2021-12-01 | Reilly John Charles | officer: General Counsel and Secretary | 318,079 | J-Other | D | 1,475 | 2.13 | 3,141.75 |
| 2021-12-01 | Braunstein Samara H. | officer: Chief Marketing Officer | 120,472 | J-Other | D | 3,278 | 0.00 | 0.00 |
| 2021-12-01 | Margolin Gil | officer: Chief Technology Officer | 121,197 | J-Other | D | 2,553 | 2.13 | 5,437.89 |
| 2021-11-23 | Braunstein Douglas L | director, 10 percent owner | 11,340,600 | P-Purchase | A | 1,000,000 | 2.08 | 2,080,000.00 |
| 2021-10-26 | Crowe Jeffrey | director | 63,402 | A-Award | A | 63,402 | 8.52 | 540,185.04 |
| 2021-10-26 | Crowe Jeffrey | director | 15,384 | A-Award | A | 15,384 | 0.00 | 0.00 |
| 2021-10-26 | Shachar Erez | director | 63,402 | A-Award | A | 63,402 | 8.52 | 540,185.04 |
| 2021-10-26 | Shachar Erez | director | 15,384 | A-Award | A | 15,384 | 0.00 | 0.00 |
| 2021-10-18 | Boyd Erin | officer: Chief Growth Officer | 10,000 | A-Award | A | 10,000 | 0.00 | 0.00 |
| 2021-10-18 | Braunstein Samara H. | officer: Chief Marketing Officer | 495,000 | A-Award | A | 495,000 | 5.81 | 2,875,950.00 |
| 2021-10-18 | Braunstein Samara H. | officer: Chief Marketing Officer | 123,750 | A-Award | A | 123,750 | 0.00 | 0.00 |
| 2021-10-18 | Margolin Gil | officer: Chief Technology Officer | 495,000 | A-Award | A | 495,000 | 5.81 | 2,875,950.00 |
| 2021-10-18 | Margolin Gil | officer: Chief Technology Officer | 123,750 | A-Award | A | 123,750 | 0.00 | 0.00 |
| 2021-10-18 | Reilly John Charles | officer: General Counsel and Secretary | 247,500 | A-Award | A | 247,500 | 5.81 | 1,437,975.00 |
| 2021-10-18 | Reilly John Charles | officer: General Counsel and Secretary | 251,762 | A-Award | A | 61,875 | 0.00 | 0.00 |
| 2021-10-18 | Frank Oren | director, officer: Chief Executive Officer | 1,732,500 | A-Award | A | 1,732,500 | 5.81 | 10,065,825.00 |
| 2021-10-18 | Frank Oren | director, officer: Chief Executive Officer | 1,700,851 | A-Award | A | 433,125 | 0.00 | 0.00 |
| 2021-10-18 | Frank Roni | director, officer: Head of Clinical Services | 495,000 | A-Award | A | 495,000 | 5.81 | 2,875,950.00 |
| 2021-10-18 | Frank Roni | director, officer: Head of Clinical Services | 1,391,476 | A-Award | A | 123,750 | 0.00 | 0.00 |
| 2021-10-18 | HIRSCHHORN MARK | officer: President and COO | 990,000 | A-Award | A | 990,000 | 5.81 | 5,751,900.00 |
| 2021-10-18 | HIRSCHHORN MARK | officer: President and COO | 788,967 | A-Award | A | 247,500 | 0.00 | 0.00 |
| 2021-10-18 | Fulk Jennifer | officer: Chief Financial Officer | 123,150 | A-Award | A | 123,150 | 0.00 | 0.00 |
| 2021-08-30 | YEANEY JACQUELINE E | director | 15,384 | A-Award | A | 15,384 | 0.00 | 0.00 |
| 2021-08-30 | Pawar Madhu | director | 15,384 | A-Award | A | 15,384 | 0.00 | 0.00 |
| 2021-08-30 | Warfield Curtis | director | 15,384 | A-Award | A | 15,384 | 0.00 | 0.00 |
| 2021-08-30 | Braunstein Douglas L | director, 10 percent owner | 15,384 | A-Award | A | 15,384 | 0.00 | 0.00 |
| 2021-08-30 | BERG CHARLES | director | 15,384 | A-Award | A | 15,384 | 0.00 | 0.00 |
| 2021-08-16 | Hudson Executive Capital LP | 10 percent owner | 17,980,600 | P-Purchase | A | 142,500 | 5.30 | 755,250.00 |
| 2021-08-13 | Hudson Executive Capital LP | 10 percent owner | 17,838,100 | P-Purchase | A | 46,000 | 5.23 | 240,580.00 |
| 2021-08-12 | Hudson Executive Capital LP | 10 percent owner | 17,792,100 | P-Purchase | A | 2,100 | 5.17 | 10,857.00 |
| 2021-07-26 | Fulk Jennifer | officer: Chief Financial Officer | 492,600 | A-Award | A | 492,600 | 6.36 | 3,132,936.00 |
| 2021-06-22 | Frank Roni | director, officer: Head of Clinical Services | 571,810 | A-Award | A | 571,810 | 0.39 | 223,005.90 |
| 2021-06-22 | Frank Roni | director, officer: Head of Clinical Services | 646,802 | A-Award | A | 646,802 | 1.21 | 782,630.42 |
| 2021-06-22 | Frank Roni | director, officer: Head of Clinical Services | 628,399 | A-Award | A | 628,399 | 0.23 | 144,531.77 |
| 2021-06-22 | Frank Roni | director, officer: Head of Clinical Services | 834,144 | A-Award | A | 834,144 | 0.51 | 425,413.44 |
| 2021-06-22 | Frank Roni | director, officer: Head of Clinical Services | 226,827 | A-Award | A | 226,827 | 1.22 | 276,728.94 |
| 2021-06-22 | Frank Roni | director, officer: Head of Clinical Services | 1,267,726 | A-Award | A | 1,267,726 | 0.00 | 0.00 |
| 2021-06-22 | Frank Roni | director, officer: Head of Clinical Services | 474,719 | A-Award | A | 474,719 | 0.00 | 0.00 |
| 2021-06-22 | Margolin Gil | officer: Chief Technology Officer | 656,990 | A-Award | A | 656,990 | 0.10 | 65,699.00 |
| 2021-06-22 | Margolin Gil | officer: Chief Technology Officer | 253,094 | A-Award | A | 253,094 | 0.39 | 98,706.66 |
| 2021-06-22 | Margolin Gil | officer: Chief Technology Officer | 523,775 | A-Award | A | 523,775 | 0.51 | 267,125.25 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Group doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Group or anyone involved with Discounting Cash Flows Group will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.